EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

A novel hybrid prosthesis for open repair of acute DeBakey type I dissection with malperfusion: Early results from the PERSEVERE trial

Wilson Y Szeto, Shinichi Fukuhara, Fernando Fleischman, Ibrahim Sultan, William Brinkman, George Arnaoutakis, Hiroo Takayama, Kyle Eudailey, Derek Brinster, Arminder Jassar, Joseph DeRose, Chase Brown und 2 weitere

The Journal of Thoracic and Cardiovascular Surgery · 2025-07 · 170 (1) · 114-123.e3

DOI: 10.1016/j.jtcvs.2024.07.059 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025-07. Verfasst von Wilson Y Szeto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pa. Electronic address: wilson.szeto@pennmedicine.upenn.edu. Hauptthemen laut MEDLINE: Aortic Dissection, Blood Vessel Prosthesis Implantation, Blood Vessel Prosthesis, Stents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Artivion Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Outcomes after hemiarch repair for acute DeBakey type I aortic dissection (ADTI) remain unfavorable, with high rates of major adverse events and negative aortic remodeling. The PERSEVERE study evaluates the safety and effectiveness of the AMDS Hybrid prosthesis, a novel bare metal stent, in patients presenting with preoperative malperfusion. METHODS: PERSEVERE is a prospective single-arm investigational study conducted at 26 sites in the United States. Ninety-three patients underwent ADTI aortic dissection repair with AMDS implantation. The 30-day primary endpoints are a composite rate of 4 major adverse events and the rate of distal anastomotic new entry tears. The secondary endpoints include aortic remodeling. RESULTS: Clinical malperfusion was documented in 76 patients (82%); only radiographic malperfusion, in 17 (18%). The median follow-up in the 93 patients was 5.6 months. Within 30 days, 9 patients died (9.7%), 10 patients (10.8%) experienced new disabling stroke, and 18 patients (19.4%) had new-onset renal failure requiring ≥1 dialysis treatment. There were no cases of myocardial infarction. The composite rate of major adverse events (27%) was lower than that reported in the reference cohort (58%). There were no distal anastomotic new entry tears. Technical success was achieved in 99% of patients. Early remodeling indicated total aortic diameter stability, true lumen expansion, and false lumen reduction in the treated aortic segment. CONCLUSIONS: Early results show significant reductions in major adverse events and distal anastomotic new entry tears, successfully meeting both primary endpoints. The technical success rate was high. AMDS can be used safely in patients with ADTI dissection with malperfusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic DissectionBlood Vessel Prosthesis ImplantationBlood Vessel ProsthesisStentsEndovascular ProceduresAortic AneurysmAortic Aneurysm, ThoracicHumansFemaleMaleMiddle AgedProspective StudiesAgedProsthesis DesignTreatment OutcomeTime FactorsUnited StatesAdultPostoperative ComplicationsVascular RemodelingRisk Factors

Stichwörter der Autor:innen

acute aortic dissectionaortic remodelinghemiarchmalperfusion

Autor:innen und Institutionen

  • Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pa. Electronic address: wilson.szeto@pennmedicine.upenn.edu.
  • Department of Cardiac Surgery, University of Michigan, Ann Arbor, Mich.
  • Department of Cardiothoracic Surgery, USC Cardiac and Vascular Institute, University of Southern California, Los Angeles, Calif.
  • Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.
  • Department of Cardiothoracic Surgery, The Heart Hospital Baylor Scott & White Plano, Plano, Tex.
  • Division of Cardiovascular and Thoracic Surgery, University of Texas, Austin, Tex.

Förderung

  • Artivion Inc

Zitieren

APA

Szeto, W. Y., Fukuhara, S., Fleischman, F., Sultan, I., Brinkman, W., Arnaoutakis, G., Takayama, H., Eudailey, K., Brinster, D., Jassar, A., DeRose, J., Brown, C., Farrington, W., & Moon, M. C. (2025). A novel hybrid prosthesis for open repair of acute DeBakey type I dissection with malperfusion: Early results from the PERSEVERE trial. The Journal of Thoracic and Cardiovascular Surgery, 170(1), 114-123.e3. https://doi.org/10.1016/j.jtcvs.2024.07.059

Vancouver

Szeto WY, Fukuhara S, Fleischman F, Sultan I, Brinkman W, Arnaoutakis G, et al. A novel hybrid prosthesis for open repair of acute DeBakey type I dissection with malperfusion: Early results from the PERSEVERE trial. The Journal of Thoracic and Cardiovascular Surgery. 2025;170(1):114-123.e3. doi:10.1016/j.jtcvs.2024.07.059

BibTeX
@article{Szeto2025,
  author = {Szeto, Wilson Y and Fukuhara, Shinichi and Fleischman, Fernando and Sultan, Ibrahim and Brinkman, William and Arnaoutakis, George and Takayama, Hiroo and Eudailey, Kyle and Brinster, Derek and Jassar, Arminder and DeRose, Joseph and Brown, Chase and Farrington, Woodrow and Moon, Michael C},
  title = {A novel hybrid prosthesis for open repair of acute DeBakey type I dissection with malperfusion: Early results from the PERSEVERE trial},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  volume = {170},
  number = {1},
  pages = {114--123.e3},
  doi = {10.1016/j.jtcvs.2024.07.059}
}
Kostenlos starten →